Pfizer Inc
XHAM:PFE
Relative Value
The Relative Value of one
PFE
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 22.785 EUR,
Pfizer Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
PFE Competitors Multiples
Pfizer Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Pfizer Inc
XHAM:PFE
|
150.3B EUR | 2.4 | 19.4 | 7.3 | 9.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
965.4B USD | 14.7 | 46.3 | 31.2 | 33.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
592B USD | 6.2 | 21.7 | 15.1 | 18.5 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
291.7B CHF | 4.8 | 31.1 | 13.1 | 15.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.7B GBP | 5.5 | 31.7 | 17.5 | 24.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
242.2B CHF | 5.5 | 22.2 | 13.7 | 17.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
301.7B USD | 4.7 | 16.6 | 10.3 | 12.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK | 4.3 | 13 | 9.5 | 11.2 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
90.6B GBP | 2.8 | 15.8 | 7.9 | 11.3 | |
| UK |
|
GSK plc
XETRA:GS71
|
103.6B EUR | 2.8 | 15.8 | 8 | 11.3 |